Skip to main content
ABEO
NASDAQ Life Sciences

Abeona Buys Phase 3-Ready APT-1011 as ABO-801, Lands $30M Private Placement

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$4.18
Mkt Cap
$238.457M
52W Low
$3.91
52W High
$7.65
52W Position info
6.9% above low
Off High info
45% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ABEO is trading near its 52-week low of $3.91 (6.9% above the low).

Summary

Abeona is adding a second late-stage asset: it acquired APT-1011, a Phase 3-ready program it will now call ABO-801, for $20 million in equity consideration at closing with no upfront cash payment, and simultaneously signed a $30 million private placement that includes leading life sciences investors. That cash is meaningful against a company that ended Q2 2026 with $146.8 million in cash and is still funding the ZEVASKYN launch, where treated patients rose from five at the Q2 report to 12 by late September. The deal broadens the pipeline beyond ZEVASKYN and the Sanfilippo program Ultragenyx took through FDA approval in September, reducing single-asset dependence. Terms of the placement — price per share and discount to the $4.18 market price — are not in the headline and will determine how dilutive this actually is. Watch the 8-K and placement pricing details for the real read on dilution and on who is funding the company.

At the time of this announcement, ABEO was trading at $4.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $238.5M. The 52-week trading range was $3.91 to $7.65. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ABEO - Latest Insights

ABEO
Nov 09, 2026, 6:35 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.01
Real-time Price: $4.01 info
Change: $0 (0%) info
Market Cap: $238.457M info
ABEO
Nov 09, 2026, 6:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.18
Real-time Price: $4.01 info
Change: -$0.1695 (-4%) info
Market Cap: $238.457M info
ABEO
Oct 23, 2026, 2:38 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $4.32
Real-time Price: $4.01 info
Change: -$0.310 (-7%) info
Market Cap: $238.457M info
ABEO
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.40
Real-time Price: $4.01 info
Change: -$1.39 (-26%) info
Market Cap: $238.457M info
ABEO
Sep 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.74
Real-time Price: $4.01 info
Change: -$1.73 (-30%) info
Market Cap: $238.457M info